[HTML][HTML] Initial immune response after exposure to Mycobacterium tuberculosis or to SARS-COV-2: similarities and differences
Tuberculosis (TB), caused by Mycobacterium tuberculosis (Mtb) and Coronavirus disease-
2019 (COVID-19), whose etiologic agent is severe acute respiratory syndrome coronavirus …
2019 (COVID-19), whose etiologic agent is severe acute respiratory syndrome coronavirus …
[HTML][HTML] The importance of measuring SARS-CoV-2-specific T-cell responses in an ongoing pandemic
Neutralizing antibodies are considered a correlate of protection against SARS-CoV-2
infection and severe COVID-19, although they are not the only contributing factor to …
infection and severe COVID-19, although they are not the only contributing factor to …
[HTML][HTML] ImmunosuppressiveTherapies differently modulate Humoral-and T-cell-specific responses to COVID-19 mRNA vaccine in rheumatoid arthritis patients
Objective To assess in rheumatoid arthritis (RA) patients, treated with different
immunosuppressive therapies, the induction of SARS-CoV-2-specific immune response …
immunosuppressive therapies, the induction of SARS-CoV-2-specific immune response …
[HTML][HTML] Kinetics of the B-and T-cell immune responses after 6 months from SARS-CoV-2 mRNA vaccination in patients with rheumatoid arthritis
Objective To assess the kinetics of the humoral and cell-mediated responses after severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination in rheumatoid arthritis …
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination in rheumatoid arthritis …
[HTML][HTML] Determinants of antibody responses to SARS-CoV-2 vaccines: population-based longitudinal study (COVIDENCE UK)
DA Jolliffe, SE Faustini, H Holt, N Perdek, S Maltby… - Vaccines, 2022 - mdpi.com
Antibody responses to SARS-CoV-2 vaccines vary for reasons that remain poorly
understood. A range of sociodemographic, behavioural, clinical, pharmacologic and …
understood. A range of sociodemographic, behavioural, clinical, pharmacologic and …
[HTML][HTML] Role of peptides in diagnostics
S Pandey, G Malviya… - International Journal of …, 2021 - mdpi.com
The specificity of a diagnostic assay depends upon the purity of the biomolecules used as a
probe. To get specific and accurate information of a disease, the use of synthetic peptides in …
probe. To get specific and accurate information of a disease, the use of synthetic peptides in …
[HTML][HTML] Manifestations and mechanism of SARS-CoV2 mediated cardiac injury
S Xu, W Wu, S Zhang - International Journal of Biological Sciences, 2022 - ncbi.nlm.nih.gov
Abstract Coronavirus disease 2019 (COVID-19), a global pandemic caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV2) had resulted in considerable morbidity …
respiratory syndrome coronavirus 2 (SARS-CoV2) had resulted in considerable morbidity …
[HTML][HTML] High levels of pro-inflammatory SARS-CoV-2-specific biomarkers revealed by in vitro whole blood cytokine release assay (CRA) in recovered and long …
SMR Gomes, ACS Brito, WFP Manfro, M Ribeiro-Alves… - Plos one, 2023 - journals.plos.org
Background Cytokines induced by SARS-CoV-2 infection play a crucial role in the
pathophysiology of COVID-19 and hyperinflammatory responses have been associated with …
pathophysiology of COVID-19 and hyperinflammatory responses have been associated with …
[HTML][HTML] Coordinated innate and T-cell immune responses in mild COVID-19 patients from household contacts of COVID-19 cases during the first pandemic wave
Objective To better define the immunopathogenesis of COVID-19, the present study aims to
characterize the early immune responses to SARS-CoV-2 infection in household contacts of …
characterize the early immune responses to SARS-CoV-2 infection in household contacts of …
[HTML][HTML] Cysteamine with in vitro antiviral activity and immunomodulatory effects has the potential to be a repurposing drug candidate for COVID-19 therapy
The ongoing pandemic of coronavirus disease-2019 (COVID-19), caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), needs better treatment options both at …
respiratory syndrome coronavirus 2 (SARS-CoV-2), needs better treatment options both at …